Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12485733Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$1.3M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#11,273
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Diana Zepeda-orozco as a PI. Multi-PI records show the full award amount for context.
- 1R01DK138101-01A1R01Targeting Tubular Mitochondrial Superoxide Dismutation in Cisplatin Renal Repair$629Kaward amount
- 1R01CA291827-01R01Optimizing Theranostic Dosimetry and Kidney Biomarkers for Alpha-Emitter Radioligand Therapy in Neuroendocrine Tumors$627.6Kaward amount
Award organization
Organizations that administered FY2024 awards listing Diana Zepeda-orozco as a PI.
FY2024 award administered by Nationwide Children's Hospital (OH).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardNationwide Children's Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2026Entered Top 50% NationallyRanked #2384
- 2026Entered Top 25% NationallyRanked #2384